OSCR · NYSE · Medical - Healthcare Plans

Oscar Health

Offers ACA individual-market health plans, ICHRA coverage, and enrollment technology.

$30.50
After-hours close+0.04 (+0.12%)
At close$30.46(+1.37%)
Loading prices…

Profile

Oscar Health, Inc.OSCRHealth Care

Sells ACA individual-market health plans, including employer-funded ICHRA coverage, and earns most revenue from premiums. An internally built insurance platform supports member navigation and plan operations, while +Oscar, Lucie Health Marketplace, Trove Group, and HealthInsurance.org extend its technology, enrollment, brokerage, and lead-generation capabilities.

Offers Affordable Care Act health plans to individuals, families, and employees using employer-funded ICHRAs across multiple U.S. states, with enrollment concentrated in Florida and Texas. Most revenue comes from insurance premiums; +Oscar sells Campaign Builder engagement technology to providers and payors.

Runs member navigation, utilization management, claims, billing, and benefits on an internally built cloud platform. Lucie Health Marketplace handles plan shopping and enrollment; Trove Group sells individual medical and supplemental coverage; HealthInsurance.org provides education and leads.

Results depend on pricing medical risk, managing claims and risk adjustment, maintaining provider networks, and meeting federal and state rate, capital, and medical-loss-ratio rules. Market participation is renewed annually, and federal advance tax credits fund most premium receipts.

Company facts

CEOMark Thomas Bertolini
ListedMar 3, 2021
ExchangeNYSE
HeadquartersNew York City, NY
CountryUnited States
Employees2,305
CIK0001568651
ISINUS6877931096

Key statistics

Market cap$7.90B
EPS (ttm)$1.40
P/E (ttm)21.76
ROE38.5%
P/B4.49
P/S0.5157
Dividend yield
Beta1.53vs XLV 0.66

Year to date +103% · Average volume (30d) 5.4M

Analysts

Price target, next 12 months$28.50−6.5%Median of 11 analysts · vs the Aug 28 close
ConsensusHold3 of 11 analysts rate it buy or better

Ratings

Target range

Latest analyst notes

DateFirmActionPrior ratingRatingPrior targetTarget
Aug 11, 2026Goldman SachsReiterateNeutral$17$30
Aug 7, 2026Robert W. BairdTarget$27
Aug 6, 2026BarclaysReiterateOverweight$35$39
Jul 28, 2026Piper SandlerReiterateOverweight$13$36
Jun 15, 2026Raymond JamesTarget$18$30

Earnings

EPS

Estimate−$0.27
ReportedDue Nov 9, 2026

Revenue

Estimate$4.70B
ReportedDue Nov 9, 2026

History

Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseNext session
Aug 6, 2026Q2 FY26$0.40$1.10+173.0%$4.73B$4.79B+1.3%−11.86%
May 6, 2026Q1 FY26$1.21$2.07+71.1%$4.89B$4.58B−6.4%+5.19%
Feb 10, 2026Q4 FY25−$0.92−$1.24−34.6%$3.12B$2.75B−12.1%+5.59%
Nov 6, 2025Q3 FY25−$0.55−$0.53+3.6%$3.05B$2.99B−2.2%+7.00%
View details

Financial highlights

12 quartersQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$3.05B$2.86B$2.99B$2.81B$4.65B$4.88B
Gross profit$786.6M$311.0M$399.7M$185.2M$1.42B$4.88B
Operating income$297.1M−$230.5M−$129.3M−$333.7M$704.1M$383.0M
Net income$275.3M−$228.4M−$137.5M−$352.6M$679.0M$361.8M
Diluted EPS$0.92−$0.84−$0.53−$1.24$2.07$1.10
Gross margin25.8%10.9%13.4%6.6%30.5%100.0%
Operating margin9.8%-8.0%-4.3%-11.9%15.2%7.8%

Fiscal years (4-quarter sums)FY21 $1.92B · FY22 $4.13B · FY23 $5.86B · FY24 $9.18B · FY25 $11.70B

Balance sheet, Jun 30, 2026Cash & short-term investments $8.56B · Total debt $431.6M · Total assets $11.23B · Shareholders' equity $2.05B

Dividends

No dividends on record.

Ownership

Institutions 80.16%207.83M sharesInsiders 5.34%13.83M sharesOther 14.50%37.61M shares

Shares outstanding 259.27M · Float 249.19M · 96.1% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
BlackRock, Inc.20.59M7.94%13FAug 7, 2026
T. Rowe Price Investment Management, Inc.13.04M5.03%13FAug 14, 2026
D. E. Shaw & Co., Inc.12.64M4.88%13FAug 14, 2026
Vanguard Portfolio Management LLC11.03M4.25%13FAug 13, 2026
Vanguard Capital Management LLC10.58M4.08%13FAug 13, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Aug 18, 2026Richard Scott Blackleyofficer: Chief Financial Officer−18,750$31.74
Jul 1, 2026Mario Schlosserdirector−47,500$31.24
Jun 30, 2026Mark T. Bertolinidirector, officer: Chief Executive Officer−624,244$28.48
Jun 29, 2026Mark T. Bertolinidirector, officer: Chief Executive Officer−614,752$29.26
Jun 26, 2026Mark T. Bertolinidirector, officer: Chief Executive Officer−591,168$29.28
View details

Peers

  • Centene

    Ambetter is the largest ACA marketplace rival

  • Elevance Health

    Anthem and Wellpoint overlap in ACA public exchanges

  • UnitedHealth Group

    UnitedHealthcare pressures exchange pricing and networks

  • Molina Healthcare

    Medicaid-style cost control overlaps in marketplace plans

  • Cigna

    Cigna is a smaller but current ACA exchange peer

CompareAfter-hours close

CompanyPriceChange
Oscar Health$30.50+0.12%$7.90B21.819.20.5+67.2%
Centene$64.94+0.28%$31.99B14.30.2+9.9%
Elevance Health$397.30+0.72%$85.54B17.514.50.4+0.1%
UnitedHealth Group$392.50−0.12%$356.86B25.318.40.8+0.4%
Molina Healthcare$200.00−0.01%$10.44B1,052.628.50.2−4.8%
Cigna$279.20+0.06%$73.69B11.58.80.3+6.6%
Median21.414.50.3+0.4%